
Home
Chapter Home
Jobs
Conferences
Fellowships
Books
Advertisement
Breast malignant, males, children
Other malignancies
Myeloid sarcoma
Reviewer: Monika Roychowdhury, M.D. (see Reviewers page)
Revised: 17 November 2012, last major update August 2012
Copyright: (c) 2001-2012, PathologyOutlines.com, Inc.
Definition
=========================================================================
● See also leukemia-acute chapter
● Neoplasm of myeloid cells associated with acute myeloid leukemia (usually as relapse), myeloproliferative or myelodysplastic disorder
Terminology
=========================================================================
● Also called granulocytic sarcoma or chloroma
● Not part of WHO breast classification
Epidemiology
=========================================================================
● Uncommon (< 100 cases reported)
● Almost always women
● Median age 52 years, range 31-73 years
Clinical features
=========================================================================
● Rarely occurs as an isolated mass (Arch Pathol Lab Med 2005;129:32)
● Need immunostains to diagnose and to prevent misdiagnosis as lymphoma or sarcoma (Breast J 2004;10:48)
● In patients with leukemia, diagnosis is typically followed by bone marrow relapse after mean 7 months (range, 1-19 months) and poor outcome (Chin Med J (Engl) 2008;121:1854)
Case reports
=========================================================================
● 25 year old woman with AML without maturation (Coll Antropol 2010;34:641)
● 40 year old woman with synchronous granulocytic sarcoma of the breast and spine (Chin Med J (Engl) 2008;121:1854)
● Elderly woman with isolated breast myeloid metaplasia 16 years after initial diagnosis (Am J Surg Pathol 1980;4:281)
● Bilateral myeloid sarcoma of breast (J Clin Oncol 2012;30:e199)
● Other cases: Eur J Gynaecol Oncol 2011;32:435, Breast J 2004;10:48
Treatment
=========================================================================
● Systemic chemotherapy (similar to acute leukemia), possibly radiation therapy (Ann Hematol 2003;82:431)
Micro description
=========================================================================
● Well to poorly differentiated to blastic tumor of immature and mature granulocytes or monocytes
● Also immature eosinophilic precursors
● Usually preserves ductal and lobular structures
● No / minimal necrosis
● Dissection of collagen by tumor cells is common (Chin Med J (Engl) 2008;121:1854)
Micro images
=========================================================================
Various images
Myeloperoxidase+ and CD43+
Positive stains
=========================================================================
Varies by type of myeloid leukemia:
● Naphthol AS-D chloroacetate esterase, myeloperoxidase, lysozyme, CD43, CD68
● Variable CD117, CD45, TdT, CD79a and PAX5
Negative stains
=========================================================================
● CD3, CD20
Molecular description
=========================================================================
● May demonstrate mutations of primary hematopoietic neoplasm / leukemia (J Clin Pathol 2010;63:558)
Differential diagnosis
=========================================================================
● Small round cell tumors (in children)
● Lymphoma
● Lobular carcinoma
End of Breast malignant, males, children > Other malignancies > Myeloid sarcoma
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com
with any questions (click here for other
contact information).